Trial Profile
Anxiety and Depression in Epilepsy: A Pilot Epileptologist-Driven Treatment Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression; Generalised anxiety disorder
- Focus Therapeutic Use
- 01 Apr 2019 Planned End Date changed from 2 May 2018 to 1 Mar 2020.
- 01 Apr 2019 Planned primary completion date changed from 2 May 2018 to 1 Mar 2020.
- 16 May 2018 Status changed from withdrawn prior to enrolment to recruiting.